James F. Oliviero III - Jun 17, 2022 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
CEO, President and Director, Director
Signature
/s/ James F. Oliviero, III
Stock symbol
CKPT
Transactions as of
Jun 17, 2022
Transactions value $
-$301,140
Form type
4
Date filed
7/1/2022, 09:30 PM
Previous filing
Apr 5, 2022
Next filing
Jan 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK Sale -$249K -228K -8.03% $1.09 2.61M Jun 17, 2022 Direct F1, F2
transaction CKPT COMMON STOCK Sale -$22.9K -21K -0.8% $1.09 2.59M Jun 21, 2022 Direct F2, F3
transaction CKPT COMMON STOCK Sale -$13.1K -12K -0.46% $1.09 2.58M Jun 22, 2022 Direct F2, F4
transaction CKPT COMMON STOCK Sale -$16.7K -15K -0.58% $1.11 2.56M Jun 23, 2022 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.06 to $1.12. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Includes shares of restricted Common Stock, which vest over various time periods.
F3 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.06 to $1.12. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.09 to $1.10. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F5 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.11 to $1.13. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.